UBS Group’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18 | Sell |
|
|||||
|
2025
Q1 | $54.7K | Buy |
|
|||||
|
2024
Q4 | $87.5K | Buy |
|
|||||
|
2024
Q3 | $6.4K | Buy |
|
|||||
|
2024
Q2 | $4.07K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $25.2K | Buy |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.71K | Sell |
|
|||||
|
2022
Q4 | $10.7K | Buy |
|
|||||
|
2022
Q3 | $15K | Buy |
|
|||||
|
2022
Q2 | $11K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $18K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $5K | Sell |
|
|||||
|
2021
Q1 | $32K | Sell |
|
|||||
|
2020
Q4 | $41K | Buy |
|
|||||
|
2020
Q3 | $9K | Sell |
|
|||||
|
2020
Q2 | $19K | Buy |
|